Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Debt to Equity: 2019

Historic Debt to Equity for Neurocrine Biosciences (NBIX) over the last 1 years, with Dec 2019 value amounting to $0.64.

  • Neurocrine Biosciences' Debt to Equity was N/A to $0.53 in Q3 2020 from the same period last year, while for Dec 2019 it was $0.64, marking a year-over-year change of. This contributed to the annual value of $0.64 for FY2019, which is N/A change from last year.
  • Latest data reveals that Neurocrine Biosciences reported Debt to Equity of $0.64 as of FY2019.
  • Neurocrine Biosciences' 5-year Debt to Equity high stood at $0.64 for FY2019, and its period low was $0.64 during FY2019.
  • Over the past 1 years, Neurocrine Biosciences' median Debt to Equity value was $0.64 (recorded in 2019), while the average stood at $0.64.